• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Modeling Glioblastoma's Tumor Microenvironment: Blood-Brain Barrier Interactions and Vascular Dynamics

Understanding how glioblastoma (GBM) disrupts the blood-brain barrier (BBB) and reshapes the vascular landscape is essential to improving therapeutic strategies for this highly aggressive brain tumor. Our study presents a multi-model approach to uncover how GBM affects BBB integrity, vascular perfusion, and immune interactions, using both vascularized GBM-on-a-chip systems and patient-derived tumor spheroids.

These advanced models replicate key features of the human brain tumor microenvironment, enabling researchers to explore GBM-driven barrier disruption, non-perfusable vessel formation, and differential cytokine signaling across GBM cell lines.

Key Features of the Models

  • Blood-brain barrier chip for analyzing GBM-induced barrier disruption
  • Vascularized GBM model incorporating endothelial cells, pericytes, astrocytes, and GBM
  • Quantification of angiogenic factor release and vascular structure changes
  • Patient-derived spheroid integration on preformed vasculature

Download the poster to see how these models are enhancing our understanding of Glioblastoma

 

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all